Bioequivalence Evaluation in Healthy Volunteers: New Generic Formulations of Sitagliptin and Sitagliptin–Metformin Fixed-Dose Combination Compared with the Originator Products

被引:0
作者
Yvonne Schnaars
Sumedh Gaikwad
Ulrike Gottwald-Hostalek
Wolfgang Uhl
Olga Ribot
Kanthikiran V. S. Varanasi
Laura Rodríguez
Javier Torrejón
Luis Gómez
机构
[1] Merck Healthcare KGaA,
[2] Galenicum Health S.L.U.,undefined
[3] Galenicum Health India Pvt. Ltd,undefined
来源
Diabetes Therapy | 2023年 / 14卷
关键词
Bioequivalence; Diabetes; Dipeptidyl peptidase-4 inhibitor; Fixed-dose combination; Metformin; Pharmacokinetics; Single-pill combination; Sitagliptin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:347 / 362
页数:15
相关论文
共 52 条
[21]  
Bergman A(undefined)undefined undefined undefined undefined-undefined
[22]  
Yi B(undefined)undefined undefined undefined undefined-undefined
[23]  
Ballav C(undefined)undefined undefined undefined undefined-undefined
[24]  
Gough SCL(undefined)undefined undefined undefined undefined-undefined
[25]  
Chwieduk CM(undefined)undefined undefined undefined undefined-undefined
[26]  
Bergman A(undefined)undefined undefined undefined undefined-undefined
[27]  
Mistry GC(undefined)undefined undefined undefined undefined-undefined
[28]  
Lupo W-L(undefined)undefined undefined undefined undefined-undefined
[29]  
Bergman AJ(undefined)undefined undefined undefined undefined-undefined
[30]  
Stevens C(undefined)undefined undefined undefined undefined-undefined